Table 2.
Incidence of impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and type 2 diabetes mellitus (DM) during the five years follow-up after hospitalisation
| Hyperglycaemia group | Normoglycaemia group | Relative risk | |
|---|---|---|---|
| Finished follow-up | |||
| - sepsisa | 70 | 139 | |
| - ACSb | 75 | 153 | |
| - other diagnoses | 48 | 106 | |
| all patients | 193 | 398 | |
| New IFG or IGT | |||
| - sepsisa | 18 | 18 | 2.1 (95% CI 1.3 to 4.1) |
| - ACSb | 19 | 17 | 2.6 (95% CI 1.4 to 4.6) |
| - other diagnoses | 10 | 14 | 1.9 (95% CI 0.9 to 3.9) |
| all patients | 47 (24.4%) | 49 (12.3%) | 2.3 (95% CI 1.6 to 3.4) |
| New Type 2 DM | |||
| - sepsisa | 13 | 6 | 5.0 (95% CI 2.0 to 12.5) |
| - ACSb | 10 | 4 | 6.0 (95% CI 1.9 to 18.5) |
| - other diagnoses | 10 | 4 | 6.0 (95% CI 2.0 to 18.1) |
| all patients | 33 (17.1%) | 14 (3.5%) | 5.6 (95% CI 3.1 to 10.2) |
| Remained normoglycaemic | |||
| - sepsisa | 39 | 115 | |
| - ACSb | 46 | 132 | |
| - other diagnoses | 28 | 88 | |
| all patients | 113 (58.5%) | 335 (84.2%) |
a includes severe sepsis and septic shock
b ACS, acute coronary syndrome (unstable angina and myocardial infarction